Where Sober Living Sits in the Recovery Continuum

Where does sober living fit in recovery?

Sober living fits beside treatment, not in place of it. A recovery residence — sober living home, recovery house, halfway house — is a substance-free place to live, usually run on peer support and shared house rules rather than clinical staff. It is where a person sleeps, not where the clinical treatment happens. Federal frameworks describe recovery itself as a process built on four dimensions — health, home, purpose, and community — and recovery housing speaks directly to the "home" dimension: a stable, safe place to live 1Ref 1Substance Abuse and Mental Health Services Administration (2012).SAMHSA's Working Definition of Recovery.Used for the framing that recovery is a process built on four dimensions — health, home, purpose, community — with many pathways, so recovery housing addresses the 'home' dimension and medication-supported recovery is a valid pathway..

Recovery housing supports recovery; it does not deliver treatment. The two run in parallel.

That placement is the whole answer to the query. People sometimes picture sober living as the last rung of a treatment ladder. It is better understood as the ground the ladder stands on — the environment that makes the clinical work stick.

What a recovery residence actually is

A recovery residence is a shared home where everyone is committed to staying substance-free, typically with house rules, curfews, drug testing, required attendance at outside meetings or treatment, and a peer or house manager rather than medical staff. Because it is not a clinical setting, it does not appear as a rung on the standardized clinical continuum. The addiction-medicine criteria that define levels of care describe a ladder from outpatient through medically managed inpatient, matched to a person's assessed severity 2Ref 2American Society of Addiction Medicine (2024).The ASAM Criteria.Used for the claim that the clinical continuum runs from outpatient through medically managed inpatient matched to assessed severity, so recovery housing is not one of those clinical levels of care and runs alongside treatment. — and recovery housing is not one of those levels.

That distinction has practical weight. A residence can provide accountability and community, but it is not equipped to manage withdrawal, prescribe, or deliver therapy. When a residence advertises itself as "treatment," that is a claim to look at carefully. What to check before choosing one — licensing, standards, finances, and the warning signs — belongs to the pages on vetting a sober living home and sober living red flags, not here.

Why the living environment carries so much weight

The place a person returns to each night shapes whether treatment holds. Research on effective care emphasizes that staying engaged for an adequate length of time is critical, and a chaotic or using household undercuts that at every turn 3Ref 3National Institute on Drug Abuse (2018).Principles of Drug Addiction Treatment: A Research-Based Guide (Third Edition).Used for the claim that staying engaged in treatment for an adequate duration is critical to outcomes, so a stable living environment supports rather than replaces treatment.. This is also why the addiction-medicine assessment gives the recovery and living environment its own dimension — ASAM dimension 6 — weighing whether home is a source of support or a source of risk.

A supportive place to live is not a luxury add-on to recovery. It is one of the conditions that makes the rest of the plan workable.

For someone leaving a residential program into an unstable or triggering home, recovery housing can be the piece that keeps the gains from unraveling. For someone whose home is already stable and supportive, it may not be needed at all. The value is relative to the person's circumstances, which is exactly why the environment is assessed rather than assumed.

Where it sits in the continuum of care

Recovery housing most commonly appears in one of two positions. First, as a step-down: a person finishes residential treatment or a partial-hospitalization or intensive-outpatient program and moves into recovery housing while continuing lighter outpatient care. Second, as a parallel support: someone doing outpatient treatment lives in recovery housing from the start because their own home is not safe for recovery.

In both cases the clinical treatment continues elsewhere and the housing runs alongside it 2Ref 2American Society of Addiction Medicine (2024).The ASAM Criteria.Used for the claim that the clinical continuum runs from outpatient through medically managed inpatient matched to assessed severity, so recovery housing is not one of those clinical levels of care and runs alongside treatment.. What recovery housing is not is a substitute for that treatment. Moving into a sober home without any ongoing clinical care repeats the mistake of treating a single step as the whole plan. Recovery housing is a stabilizing environment, and the evidence is clear that environment plus treatment beats environment alone 3Ref 3National Institute on Drug Abuse (2018).Principles of Drug Addiction Treatment: A Research-Based Guide (Third Edition).Used for the claim that staying engaged in treatment for an adequate duration is critical to outcomes, so a stable living environment supports rather than replaces treatment.. Supporting a person's recovery at home, whether that home is a sober residence or their own, is its own subject covered separately.

Recovery housing and medication for addiction

One question decides whether a recovery residence is safe for many people: does it allow medication for opioid use disorder? The three FDA-approved medications — methadone, buprenorphine, and naltrexone — are core treatment for opioid use disorder, and the federal consensus reference treats them as legitimate, evidence-based care that recovery supports should reinforce, not obstruct 5Ref 5Substance Abuse and Mental Health Services Administration (2021).TIP 63: Medications for Opioid Use Disorder — Full Document.Used for the claim that methadone, buprenorphine, and naltrexone are the three FDA-approved medications for opioid use disorder and are legitimate, evidence-based care that recovery supports should reinforce..

Some residences, on an abstinence-only reading, bar residents who take methadone or buprenorphine. For a person with opioid use disorder, that policy is not neutral — it can force a choice between housing and the treatment with the strongest evidence behind it, and abrupt discontinuation raises overdose risk. Whether being on medication is "really" recovery is a question SAMHSA's working definition of recovery answers plainly: recovery is defined by many pathways, and medication-supported recovery is one of them. A residence that treats medication as disqualifying is a residence to screen out.

The oversight gap, and why choosing carefully matters

Recovery housing is loosely regulated, and that has consequences. Federal investigators have documented recovery-housing and patient-brokering schemes in multiple states — operators recruiting people into beds and then billing insurance for unnecessary services — and found that oversight varies widely from state to state 4Ref 4U.S. Government Accountability Office (2018).Substance Use Disorder: Information on Recovery Housing Prevalence, Selected States' Oversight, and Funding.Used for the claim that federal investigators documented recovery-housing and patient-brokering schemes in multiple states and that recovery-housing oversight varies widely by state.. There is no single national license for a sober home, which means quality ranges from excellent to predatory.

The law has teeth in places: a 2018 federal statute gives regulators authority against deceptive substance-use-treatment marketing, and enforcement has produced multi-million-dollar settlements against operators that misled people seeking help 6Ref 6Federal Trade Commission (2025).Enforcing the Opioid Addiction Recovery Fraud Prevention Act: The FTC's settlement with Evoke Wellness.Used for the claim that a 2018 federal statute gives regulators authority against deceptive substance-use-treatment marketing, with enforcement producing multi-million-dollar settlements.. But enforcement is after the fact. The protection that works in advance is knowing how patient brokering operates and how to vet a residence before moving in. Those methods live on their own pages; the takeaway here is that "where it fits" comes with a caution — the category is real and useful, and it is also one that bad actors exploit.